Stockideas

SPDR S&P 500 ETF Trust
(:SPY)
SPDR S&P 500 ETF Trust

SPDR S&P 500 ETF Trust is an Exchange traded fund. The fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index. The S&P 500® Index is composed of five hundred selected stocks. SPDR S&P 500 ETF Trust was founded on January 22, 1993 and is headquartered in New York, NY.
Sector: Miscellaneous
Industry: Investment Trusts/Mutual Funds
Stock price: $406.87 (-0.12%)
Penny Stocks & What To Watch In The Stock Market This Week Nov 21-Nov 25
By: pennystockstobuy lazy guy    
   on Nov 20, 2022

Penny stocks, by definition, are some of the cheapest assets you can buy in the stock market today. In light of this year’s stock market crash, chances are high that some of the companies you use products from each day are trading at these sub-$5 levels. Plenty of household name stocks like BuzzFeed (NASDAQ: BZFD), BurgerFi (NASDAQ: BGI), Trivago (NASDAQ: TRVG), Oatly (NASDAQ: OTLY), and countless others are in the bargain bin in 2022.Click Here To Watch TTG Live On YouTube
Most of the tensions have risen from the outlook on inflation, interest rates, and the massive Fed balance sheet. But some are hoping for a corner to be turned sooner than later. The latest round of October CPI and October PPI inflation data supports the idea that policy measures may have started working. But that doesn’t mean we’re out of the woods quite yet.

Conflicting information from the November Fed meeting still has investors torn. While the Fed statement read one way, comments from Chairman Jerome Powell suggested a different tone. Meanwhile, last week, hawkish Fed member commentary and geopolitical uncertainty saw markets cool. Regardless, indexes, including the S&P 500 (NYSEARCA: SPY), managed to hold support by Friday’s close, only shedding 63 cents compared to Monday’s opening bell.

Meanwhile, the Dow continued churning higher and closed on the week with a slight gain compared to last Monday’s open. Given the shortened week, some presume a lighter and less serious economic and central bank data schedule. But rest assured, plenty could move markets over the next five days.

The Stock Market This Week: Key Economic Data To Know November 21st – November 25th

One of the more significant focuses of the week will be the meeting minutes from the November FOMC meeting. While we know the general outlook thanks to the Fed press conference and the statement, the meeting minutes from November’s Federal Open Market Committee meeting could give even more color on what happened.

We’ll also see global central banking catalysts, including the ECB’s account of its latest monetary policy meeting. There will also be plenty of central banker speeches, economic data, and earnings results to consider.

– 5 Penny Stocks To Buy According To Analysts, Targets Up To 1,050%

stock market news stock market economic events this week november 21 november 25

Stock Market News & Events On Monday, November 21, 2022

Monday and Friday will be the lightest days for economic data and central banker speeches. The European Central Bank’s Fernandez-Bollo and Bank Of England’s Cunliffe speak at two separate events. Meanwhile, as the premarket session moves closer to the opening bell, we’ll also get some US economic data with Chicago Fed National Activity at 8:30 AM ET.

Stock Market News & Events On Tuesday, November 22, 2022

Tuesday begins to see a more active schedule of events with FOMC speakers throughout the day, including Mester, George, and Bullard. We’ll also get a flavor of retail sales activity from the next round of Redbook data coming before the bell. Later on in the afternoon, following the closing bell, the newest API weekly crude figures come out.

What Is The Redbook?

Red Book data shows sales-weighted year-over-year same-store sales trends. It can signal consumer spending and short and medium-term trends for retail investors and track a wide range of retail categories. Everything from sporting goods and apparel to jewelry and home furnishings is followed closely in the Red Book. The last reading came in at 6.8%, which was lower than the 7.6% previously. Redbook data spiked from week-to-week October 25th to November 1st (8.2% to 9.7%) but has steadily declined throughout November.

Stock Market News & Events On Wednesday, November 23, 2022

Wednesday, November 23rd, is the most active day of the week for economic data and central bank speaking engagements. It kicks off with the ECB’s Fernandez-Bollo and De Guindos speaking. We also get the Eurozone’s November Purchasing Managers’ Index (PMI) data for manufacturing, services, and S&B global composite. UK PMI will also be released during the early morning hours on November 23rd.

– Best Penny Stocks To Buy? 7 To Watch Under $1 Right Now

Forecasts remain below 50 for this next round, which suggests a generally contractionary climate. PMI is looked at by traders as a means for gauging economic performance since purchasing managers tend to have initial access to company performance data. The MPC’s Pill, Ramsden, and Mann speak before the U.S. markets open.

Regarding economic data, US Building Permits, jobless claims, durable & core durable goods, home sales, crude inventories, and Michigan consumer sentiment get released during the morning. This leads to the 2 PM ET release of the November FOMC minutes. Here’s what was reported in the last FOMC minutes.

Stock Market News & Events On Thursday, November 24, 2022

US markets close on Thursday in celebration of the Thanksgiving holiday. But that doesn’t mean everything stops as far as global events are concerned. Central bank speakers include the MPC’s Ramsden, Mann, & Pill and the ECB’s De Guindos, Schnabel, and Enria. For economic data, you can look for clues from the ECB’s monetary policy meeting account and the UK Confederation of British Industry (CBI) industrial trends orders data.

Stock Market News & Events On Friday, November 25, 2022

Friday is quiet as US markets close early on Black Friday at 1 PM ET. ECB speakers include Jochnick and De Guindos to round out the week.

– What Do Penny Stocks Need to Succeed in 2022?

Stock Market Outlook For The Week Ahead: 11/21 to 11/25

This week is a bit lighter regarding the frequency of economic events. But when it comes to the potential impact that these events can have on the market is a different story. Surely, Wednesday’s FOMC meeting minutes will bring some market volatility and a possible reaction on Friday from Thursday’s ECB and UK data.

Nevertheless, things like the FTX crypto brokerage meltdown and the Russia-Ukraine war could bring additional headline risk to account for. Against this backdrop, some notable companies are still reporting earnings, and the market will likely hang on the words of management to gain insight into the guidance & outlook for the next few quarters.

Thanks to this stock market roller coaster ride, every trader and investor is asking the same questions:

  • What Happens Next in The Stock Market?
  • Is this the stock market bottom for 2022?
  • Is it time to sell Bitcoin, Ethereum & other cryptocurrencies?
  • How should you be investing money into your long-term portfolio?
  • What stock market news this week will move the market next?
  • How Can I Make Money trading in The Stock Market?
  • What are the best stocks to buy now?

Playing “the stock market game” has worked for those who are prepared and strategically positioning themselves to take advantage of the opportunity to make money trading every day. The stock market opens at 9:30 AM ET and gives participants plenty of time to react to daily market trends. It’s not with one specific stock market indicator or some magical stock market analysis.

If you have ever wondered How to start investing in the stock market, How the stock market works, asked yourself, “is this a stock market for beginners” or wondered how to start investing in stocks for the long term, it’s time to pay attention.

Find out LIVE when you tune in to True Trading Group’s Stock Market LIVE Stream tonight on YouTube & Get Ready to Learn, Trade & Profit!

Notable Earnings In The Stock Market This Week

Monday, November 21, 2022, Most Anticipated Earnings

  • Agilent Technologies, Inc. (A)
  • Dell Technologies (DELL)
  • Zoom Video (ZM)
  • Jacobs Solutions (J)
  • JM Smucker (SJM)
  • Toro Company (TTC)
  • Futu Holdings (FUTU)
  • Urban Outfitters (URBN)
  • DouYu International (DOYU)
  • Niu Technologies (NIU)

Tuesday, November 22, 2022, Most Anticipated Earnings

  • Medtronic (MDT)
  • Analog Devices (ADI)
  • Autodesk (ADSK)
  • Dollar Tree (DLTR)
  • Baidu (BIDU)
  • HP Inc. (HPQ)
  • Best Buy (BBY)
  • Warner Music Group (WMG)
  • Burlington Stores (BURL)
  • Dick’s Sporting Goods (DKS)
  • Nordstrom (JWN)
  • Chinadata Group (CD)
  • Canadian Solar (CSIQ)
  • American Eagle Outfitters (AEO)
  • Jack In The Box (JACK)
  • Guess (GES)
  • Abercrombie & Fitch (ANF)
  • Chico’s FAS (CHS)
  • Movado Group (MOV)

Wednesday, November 23, 2022, Most Anticipated Earnings

  • Deere & Company (DE)
  • Full Truck Alliance (YMM)
  • Kingsoft Cloud (KC)
  • Partner Communicaitons (PTNR)

Friday, November 25, 2022, Most Anticipated Earnings

  • Natuzzi (NTZ)

SOURCE


Reply
Relaxing Meditation Music For Studying The Stock Market | LoFi Hip Hop Beats For Everyone Doing Research Today
By: pennystocks Penny Stocks [pennystocks.com]    
   on Jul 26, 2021

https://youtu.be/tCWd_gD8kfY

https://youtu.be/tCWd_gD8kfY via #PennyStocks

$SPY $QQQ $DIA


Reply
Biotech Penny Stocks & Small Caps Gain Ground After Cytokinetics Gets Boost On News
By: pennystocks Penny Stocks [pennystocks.com]    
   on Jul 19, 2021

When it comes to penny stocks or small-caps, in general, sector & industry trends can play a role. Broader markets and indexes like the S&P 500 ETF (NYSE: $SPY) and Nasdaq ETF (]NASDAQ: $QQQ](https://pennystocks.com/ticker/?symbol=QQQ)) have slumped. But some companies are enjoying a strong move on Monday. For instance, Cytokinetics Inc. (NASDAQ: $CYTK) shares jumped to some of their highest levels in nearly a year. This came after the company announced positive topline results from 2 cohorts in its REDWOOD-HCM Phase 2 clinical trial of CK-3773274 (CK-274). This is the company’s investigational treatment targeting hypertrophic cardiomyopathy.

“The combined data from Cohorts 1 and 2 in REDWOOD-HCM met our high expectations for this trial of CK-274 in patients with obstructive HCM, given the observed onset of response to initiation of treatment, magnitude and breadth of response, reversibility of LVEF decreases, and favorable tolerability profile,” said Fady I. Malik, M.D., Ph.D., Cytokinetics’ Executive Vice President of Research & Development.

[Read More] 3 Former Penny Stocks To Watch This Week As Earnings Season Kicks Off

Thanks to these results, Cytokinetics expressed its anticipation of what its Phase 3 trial could bring to the table. Let’s put this into perspective. CYTK wasn’t any of the penny stocks that broke out last year. However, its valuation was a fraction of what it is today. Last October, CYTK stock was trading around $15 a share; more than 50% less than its value on July 19th. With that, attention is certainly on smaller biotech stocks right now.

Penny Stocks & Small Cap Biotechs Gain Attention On Sympathy Trend

With this news placing attention on smaller biotech companies, it will be interesting to see how things play out at the start of the week. A few things to note are that both broader small-caps and biotech, in general, are feeling the pressure from the market’s early sell-off this week. However, some stand-outs could present some potential early on as well. At the end of the day, broader trends don’t always dictate the pace for smaller stocks (including penny stocks). This shortlist includes a few names to watch that’ve bounced while broader markets slid.

  • GT Biopharma Inc. (NASDAQ: GTBP)

  • Iveric Bio (NASDAQ: $ISEE)

  • NRX Pharmaceuticals Inc. (NASDAQ: $NRXP)

GT Biopharma Inc. (NASDAQ:GTBP)

Roughly 4 months ago, GT Biopharma (GTBP Stock Report) was trading as a penny stock. Shares of the biotech company hovered under $5 a share as the company began rolling out its plan to advance a novel treatment pipeline. Built on the framework of its tri-specific killer engager cell technology (TriKE), GTBP stock has managed to turn heads in a short period of time.

One of the unique traits of GT is that early clinical data has already shown the potential of its treatment technology. The company’s lead candidate, GTB-3550, for instance, has demonstrated effective treatment in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS). So far, 11 patients have completed treatment in the GTB-3550 Phase 1 clinical trial. According to the company, Patients 5, 7, 9, and 11 experienced 33%, 61%, 63% and 50% reduction in CD33+ AML/MDS bone marrow blast levels, respectively. The Phase 1 safety portion is expected to finish up in late August with a data publication scheduled for the end of September. Considering the early progress and near-term potential catalysts, GTBP stock has found itself on watch lists this year.

What’s more, aside from GTB-3550, the company’s other TriKE candidates have demonstrated efficacy in combination with other treatments. For instance, GT Biopharma’s B7H3 TriKE was combined with Fate Therapeutic’s (NASDAQ: $FATE) FT538 iNK cells targeting tumor cells in prostate cancer. While FT538 alone showed a slight impact to cells in the model, the combination with GT’s TriKE demonstrated a complete eradication of cancer cells:

best penny stocks small cap to watch GT Biopharma GTBP stock

GTBP TriKE treatment gtb5550 Additionally, GT Biopharma’s CEO, Anthony Cataldo told PennyStocks.com that:

“GT Biopharma’s TriKE™ technology is a clear breakthrough in cancer treatment. Not only has it shown early success in hematologic diseases like acute myeloid leukemia, the potential demonstrated in combination with Fate’s FT538 iPSC NK cells opens up endless possibilities for the application of TriKE combination treatment in other potential drug therapy platforms targeting things like IL-15.”

Iveric Bio (NASDAQ: ISEE)

Another one of the former biotech penny stocks to watch right now is Iveric Bio (ISEE Stock Report). Last August, shares of ISEE stock were trading below $4 at one point. Fast-forward to this year and the former penny stock has reached highs of $10.25. Given the momentum that has built up just recently, Iveric Bio has experienced a strong surge in interest. What seems to have helped spark the action, began when Wedbush updated its stance on ISEE. The firm boosted its price target to $15 from $11 and maintained its Outperform rating.

[Read More] 3 Top Penny Stocks For Your Monday Morning Watchlist

Following this, the company received an FDA agreement for its GATHER2 Phase 3 clinical trial. This trial is focused on Iveric’s Zimura for geographic atrophy. Why was this important? This special protocol assessment provided the company with an official evaluation and guidance on the design for a protocol aimed at creating the basis for a new drug application.

The company expects to finish enrollment of this trial by the end of this month. It also brought on a new Chief Commercial Officer, Christopher Simms, who comes from a strong background in biotech prowess. Simms joins Iveric from Novartis where he managed commercial operations and launched BEOUV for wet age-related macular degeneration. Simms also served at Genentech. With the addition of a new CCO and anticipated completion of enrollment in this next trial, ISEE stock may be one to watch before the end of July.

best penny stocks small cap to watch Iveric Bio Inc. ISEE stock chart

NRX Pharmaceuticals Inc. (NASDAQ: NRXP)

Shares of NRXP were also going against the grain of the broader biotech trend at the start of the week. NRX Pharmaceuticals (NRXP Stock Report) announced that it will present data at the Disease Control and Prevention Summit this week. Wednesday (7/21) the company provides evidence that its YESAMI treatment might help prevent “cytokine storm” in patients with COVID-19.

According to the company, “In the recently-completed phase 2b/3 trial, patients treated with placebo experienced a statistically significant elevation in interleukin 6 (IL-6) cytokine levels, whereas those treated with ZYESAMI™ had a minimal increase in IL-6. Change in cytokine level was a prespecified endpoint of the study.”

The data were submitted to the FDA as a supplement to its pending Emergency Use Authorization application. The company has also planned on submitting a biomarker letter of intent to the FDA. NRX has explained that cytokine release syndrome or “cytokine storm” has been related to mortality in a number of conditions including Acute Respiratory Distress Syndrome. Since these data also have to do with a pending EUA application for ZYESAMI, Wednesday’s further details may be something to keep mindful of heading into the week. Needless to say, this small cap stock has seen a strong move over the last few days. Shares rallied from around $8 in post-market trading on July 16th to highs of over $11 on Monday.

best penny stocks small cap to watch NRX Pharmaceuticals NRXP stock chart

Are Small Caps or Penny Stocks On Your List Right Now?

There’s plenty of potential with smaller stocks. But just like any investment, it’s important to be mindful of volatility. In general, the smaller the company, the more fluctuations it may see in the stock market. Understanding things like what’s potentially upcoming that might be a catalyst, key technical levels on a chart, and other trading topics to use are key to finding opportunities. In the stock market today, some of the names on this list could be ones to watch as the market finds its range in July.

biotechstocks Pursuant to an agreement between Midam Ventures LLC and GT Biopharma (GTBP) Midam has been paid $150,000 for a period from March 1, 2021, to April 1, 2021. This compensation is payment 1 of 12 as part of a 12-month agreement between Midam Ventures LLC & GT Biopharma (GTBP), for a period from March 1, 2021, to February 28, 2022. Midam Ventures LLC expects to be paid $150,000 per month for a total of 12 months by GT Biopharma (GTBP). Midam has been paid an additional $150,000 for a period from April 2, 2021, to May 1, 2021. This compensation is payment 2 of 12 as part of the Agreement. Midam has been paid an additional $150,000 for a period from May 2, 2021, to June 1, 2021. This compensation is payment 3 of 12 as part of the Agreement. Midam has been paid an additional $150,000 for a period from June 2, 2021, to July 1, 2021. This compensation is payment 4 of 12 as part of the Agreement. Midam has been paid an additional $200,000 for a period from July 2, 2021, to August 2, 2021. This compensation is payment 5 of 12 as part of the Agreement. We may buy or sell additional shares of GT Biopharma (GTBP) in the open market at any time, including before, during, or after the Website and Information, to provide public dissemination of favorable Information about GT Biopharma (GTBP). Click Here For Full Disclaimer

See Original


Reply
How To open An E*Trade Account
By: pennystocks Penny Stocks [pennystocks.com]    
   on Jul 12, 2021

https://youtu.be/s9CX7gL2JEw

https://youtu.be/s9CX7gL2JEw If you're just getting started in the stock market today, you're going to need to have a way to trade stocks. Whether we're talking about penny stocks or higher priced ones, a good platform is necessary. Making sure you have a way to track level 2, set up stock charts, and a good stock screener are definitely in the plus column.

ETrade is another one of the trading platforms that many traders use. In this video, we'll show you the steps to take if you're searching for how to open an Etrade account or looking to gain access to platforms like ETrade Pro

After You're Done Watching, You Can Start To Read Top Articles About Hot Penny Stocks To Watch Right on https://pennystocks.com

$SPY $DIA $QQQ $XLK $XLU $XLRE


Reply